Current evidence and future of automated erythrocyte exchange in the treatment of severe malaria (Q38052021)

27 August 2017

title

Current evidence and future of automated erythrocyte exchange in the treatment of severe malaria (English)

1 reference

27 August 2017

0 references

1 reference

Michael Ramharter

0 references

Lorenz Auer-Hackenberg

1 reference

27 August 2017

Stefan Winkler

1 reference

27 August 2017

Wolfgang Graninger

1 reference

27 August 2017

Nina Worel

1 reference

27 August 2017

publication date

13 October 2012

1 reference

27 August 2017

published in

Vienna Clinical Weekly

1 reference

27 August 2017

volume

124 Suppl 3

1 reference

27 August 2017

page(s)

23-26

1 reference

Treatment of severe malaria in the United States with a continuous infusion of quinidine gluconate and exchange transfusion

27 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00508-012-0238-6

Exchange transfusion as an adjunct therapy in severe Plasmodium falciparum malaria: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00508-012-0238-6

Hyperparasitemia and blood exchange transfusion for treatment of children with falciparum malaria.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00508-012-0238-6

Treatment of fulminant falciparum malaria with erythrapheresis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00508-012-0238-6

Exchange transfusion in sickle cell disease using a continuous-flow blood cell separator

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00508-012-0238-6

Automated Erythrocyte Exchange in Fulminant Falciparum Malaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00508-012-0238-6

Apheresis for severe malaria complicated by cerebral malaria, acute respiratory distress syndrome, acute renal failure, and disseminated intravascular coagulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00508-012-0238-6

Automated exchange transfusion for life-threatening plasmodium falciparum malaria--lessons relating to prophylaxis and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00508-012-0238-6

Automated erythrocytapheresis in the treatment of severe falciparum malaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00508-012-0238-6

Red cell exchange, erythrocytapheresis, in the treatment of malaria with high parasitaemia in returning travellers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00508-012-0238-6

Automated RBC exchange transfusion:treatment for cerebral malaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00508-012-0238-6

Erythrocytapheresis for Plasmodium falciparum infection complicated by cerebral malaria and hyperparasitemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00508-012-0238-6

Red blood cell exchange transfusion as an adjunct treatment for severe pediatric falciparum malaria, using automated or manual procedures

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00508-012-0238-6

Automated erythrocytapheresis in severe falciparum malaria: A critical appraisal.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00508-012-0238-6

Cytapheresis in the treatment of cell-affected blood disorders and abnormalities

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00508-012-0238-6

Automated erythrocytapheresis as treatment of severe malaria. Study of 6 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00508-012-0238-6

Automated erythrocytapheresis for severe falciparum malaria.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00508-012-0238-6

Rapid increases in parasitemia following red cell exchange for malaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00508-012-0238-6

Automated red blood cell exchange as an adjunctive treatment for severe Plasmodium falciparum malaria at the Vienna General Hospital in Austria: a retrospective cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00508-012-0238-6

UK malaria treatment guidelines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00508-012-0238-6

Guidelines on the use of therapeutic apheresis in clinical practice--evidence-based approach from the Apheresis Applications Committee of the American Society for Apheresis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00508-012-0238-6

Treatment of malaria in the United States: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00508-012-0238-6

Treatment of malaria in Austria: hazardous for patients or physicians?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00508-012-0238-6

Artesunate versus quinine for treatment of severe falciparum malaria: a randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00508-012-0238-6

Artesunate-clindamycin versus quinine-clindamycin in the treatment of Plasmodium falciparum malaria: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00508-012-0238-6

Severe falciparum malaria. World Health Organization, Communicable Diseases Cluster

21 January 2018

1 reference

12 December 2020

The use of drotrecogin alfa in severe falciparum malaria.

1 reference

12 December 2020

Treatment of severe malaria by exchange transfusion

1 reference

12 December 2020

Treatment of cerebral malaria by erythrocyte exchange

1 reference

12 December 2020

Red cell exchange using cell separator (therapeutic erythrocytapheresis) in two children with acute severe malaria

1 reference

12 December 2020

10.1007/S00508-012-0238-6

Identifiers

DOI

1 reference

Dimensions Publication ID

27 August 2017

1019199775

0 references

1 reference